Trial information
Starting Basal Rate Profiles Used in Continuous Subcutaneous Insulin Infusion.
Status: Completed
Protocol number: DMS-01-CIRCADIAN-01
Company division: Diagnostic
Official Scientific Title: Comparison of basal (fasting) glycemic control in type 1 diabetic patients with CSII achieved by the circadian slide ruler scale or flat basal rate.
Brief summary: This is a pilot trial to establish study procedures that allow comparison of various starting basal rate profiles used in Continuous Subcutaneous Insulin Infusion (CSII). Glycemic control achieved by carcadian 'slide ruler scale' basal rate versus that achieved by one constant basal rate (flat profile) will be compared during a composite fasting day as well as therapeutic success after 2 weeks of normal activity.
Study type: Interventional; Randomized; Open Label study
Condition: Diabetes Mellitus, Type 1
Intervention type: Device
Intervention name: Accu-Chek Spirit insulin pump
Inclusion criteria:
- adult patients >=18 years of age;
- type 1 diabetes;
- diabetic for >2 years, and treated with CSII for >=3 months;
- HbA1c <=8.5%.
Exclusion criteria:
- excessive fibrosis or lipo-hypertrophy at injection or infusion sites;
- unstable chronic disease other than type 1 diabetes;
- severe hypoglycemic event within last week prior to study start;
- severe diabetic ketoacidosis within last month prior to study start.
Gender: Males or Females
Age limits: Min: 18 Years Max: N/A (No limit)
Anticipated start date: January, 2006
Trial registration date: 12/04/2007
Date last updated: 10/15/2008
Link to trial result
This trial was conducted at the following locations:
Germany
